Quantcast
Last updated on May 29, 2012 at 17:24 EDT

PHC, Inc. Announces Financial Results for the Second Quarter of Fiscal 2007

February 13, 2007
Repost This

PEABODY, Mass., Feb. 13 /PRNewswire-FirstCall/ — PHC, Inc., d.b.a. Pioneer Behavioral Health (BULLETIN BOARD: PIHC) , a leading provider of inpatient and outpatient behavioral health services, today announced its fiscal 2007 second quarter financial results, for the period ended December 31, 2006.

                          Key Financial Indicators            (all numbers in thousands, except per-share amounts)                                Q2 2007     Q2 2006      Increase    % Change                                                        (decrease)    Consolidated revenues        $9,952       $8,702       $1,250       14.4%   Patient care revenues        $7,947       $6,465       $1,481       22.9%   Pharmaceutical study    revenues                      $874       $1,084        $(210)     (19.4%)   Contract support service    revenues                    $1,132       $1,153         $(21)      (1.8)%   Income from operations         $605         $549          $56       10.2%   Pretax Income                  $423         $411          $12        2.9%   Net Income                     $261         $347         $(86)     (24.8%)   Earnings per share – Basic    $0.01        $0.02       $(0.01)     (50.0%)                        Diluted  $0.01        $0.02       $(0.01)     (50.0%)      Financial Results  

Total net revenue from operations increased 14.4 percent to $10.0 million for the three months ended December 31, 2006 from $8.7 million for the three months ended December 31, 2005. Net patient care revenue increased 22.9 percent to $7.9 million for the quarter from $6.5 million for the same quarter last year. This increase in revenue is due primarily to the addition of the 20 adjudicated juvenile beds at Detroit Behavioral Institute, which contributed to a 12.2 percent increase in patient days for the three months compared to the same period last year. Revenue from pharmaceutical studies decreased 19.4 percent to $874,000 for the quarter compared to $1.1 million for the three months ended December 31, 2005 due to the cyclical nature of the pharmaceutical research business, where the size and number of clinical trial starts and stops change daily. Contract support services revenue provided by Wellplace decreased 1.8 percent to $1.1 million for the quarter from $1.2 million for the same quarter last year.

“The investments and developments we have made in our Patient Care segment during fiscal 2006 have begun to yield the significant contributions to our revenues that we anticipated,” commented Bruce A. Shear, President and Chief Executive Officer of Pioneer Behavioral Health. “The 22.9 percent increase in patient care revenue resulted from the addition of the 20 adjudicated juvenile beds at Detroit Behavioral Institute, which enabled a 12.2 percent increase in patient days for the quarter. This also represented an acceleration of 560 basis points in patient care revenue growth compared to the first fiscal quarter of 2007. We continue to view bed count as a key metric of our financial health, and even as we currently have the highest bed count totals and patient days levels in our Company’s history, we stand poised to further accelerate this growth next year following the planned expansion in Las Vegas.”

Total operating expenses for the quarter increased 15.0 percent to $9.3 million from $8.2 million during the second quarter of last year. Included in this increase was a 28.9 percent increase in patient care expenses. Through January 2007, the Company has invested approximately $500,000 in the Las Vegas market, including $400,000 in the Seven Hills project and $100,000 in the start-up of our 10-year, $80 million agreement with Health Plan of Nevada’s Behavioral Healthcare Options network agreement. The increase in operating expenses also included a $100,100, or 17.1 percent, increase in other expenses and 13% higher administrative costs to $369,000, compared to last year’s period, which was primarily due to various set-up and other infrastructure costs necessitated by the expansion at Detroit Behavioral Institute and our new software installation.

Income from operations for the quarter was $605,000, up 10.2 percent from the $549,000 reported for the same period last year. Interest expense of $212,000 was 21 percent higher, due in large part to an earn-out related $80,000 increase in interest expense at Pivotal Research Centers. Net income for the three months was $261,000, or $0.01 per fully diluted share (based on 19.4 million fully diluted shares) compared to net income of $347,000, or $0.02 per fully diluted share (based on 19.3 million shares) for the second quarter last year.

This year’s second fiscal quarter was the second consecutive quarter in which the Company recorded an income tax provision assuming an estimated 39 percent corporate tax rate, while in the prior-year quarter, the Company recorded a 16 percent tax rate for the income tax provision. Had the Company incurred the same 39 percent tax rate in the year-ago period, net income for the second quarter of fiscal 2006 would have been $255,000, which is marginally lower than in this year’s second quarter.

The Company’s provision for doubtful accounts in the quarter decreased to $347,000 from $476,000 in the year-ago same period. The percentage of bad debt expense to net patient care revenue for the quarter ended December 31, 2006 was 4.4 percent compared to 7.4 percent last year.

For the six-month period ended December 31, 2006, total net revenue from operations increased 13.4 percent to $20.0 million compared to $17.6 million for the first six months last year. Net patient care revenue increased 20.1 percent to $15.8 million for the six months from $13.2 million for the same period last year. Revenue from pharmaceutical studies decreased 19.5 percent to $1.9 million for the six-month period from $2.4 million for the same period last year. Contract support services revenue provided by Wellplace increased 9.0 percent to $2.3 million for the six months from $2.1 million for the six months ended December 31, 2005.

Patient care expenses in treatment centers increased 25.1 percent to $8.2 million for the six months from $6.6 million last year. Patient care expenses related to pharmaceutical or research division decreased 15.4 percent to $908,000 for the six months from $1.1 million last year. Contract support services expenses increased 28.8 percent to $1.5 million for the six months from $1.2 million last year. Administrative expenses increased 15.5 percent to $6.2 million for the six months from $5.4 million for the six months ended December 31, 2005.

Income from operations was $1.2 million for the first six months of both fiscal 2007 and 2006. Net income was $544,000, or $0.03 per basic and fully diluted share (based on 19.3 million shares), down 25.5 percent compared to the $731,000, or $0.04 per basic and fully diluted share (based on 19.3 million shares) last year. Our blended average tax rate for the six-month period this year was 39% as compared to 18% in last year’s same period. Adjusting last year’s six-month result for this year’s comparable tax rate, our net income would have been $544,000, largely unchanged compared to this year’s same period.

Mr. Shear continued, “Our presence in the Las Vegas metropolitan area, which we expect to be a key driver of our future growth, continues to expand. The opening of the Seven Hills Behavioral Institute will be complemented by the strong and growing presence of our Harmony Healthcare subsidiary, which serves 21 separate properties in that area. We are excited to announce that we have begun work on the 10-year, $80 million contract with Health Plan of Nevada, as announced in December, under which Harmony will continue to provide inpatient hospitalization services, outpatient services, individual and group therapy, medication management, psychological testing, as well as crisis and triage care for all Health Plan of Nevada and Behavioral Healthcare Options members in Southern Nevada and Northwestern Arizona.”

The Company reported $4.1 million in cash as of December 31, 2006, compared to $1.8 million in June 30, 2006. The increase in the cash account was primarily due to $2.0 million in new equity financing that the company received at the end of the quarter. Consequently, the Company’s balance sheet had a current ratio of 2:3 on December 31, 2006 and stockholders’ equity increased 21.7 percent to $16.4 million as of December 31, 2006 from $13.5 million as of June 30, 2006.

Mr. Shear concluded, “We are pleased with the quarterly results, and look forward to a strong second half of the year. Despite certain necessary incremental expenses associated with the $80 million contract we closed with Behavioral Healthcare Options, we had healthy operating cash flow of $1.3 million, pre-tax income of $423,000, which is close to its historical high point in this seasonably slower quarter for us, and maintained profitability for the 24th consecutive quarter. Our balance sheet continues to strengthen as well, as evidenced by our higher cash position and ability to pay down our revolving credit line and term loan debt, which we reduced by $497,000 and $500,000, respectively. We have cause for optimism as we progress towards our long-term strategic goals.”

Teleconference Information

The Company will host a conference call to discuss the fiscal 2007 second quarter results on Wednesday, February 14, 2007 at 9 a.m. Eastern Time. Interested parties within the United States can access the call by dialing 866-277-1184 and international callers may dial 617-597-5360. Please use passcode 47122216. A replay of the call also will be available until February 21, 2007 at 888-286-8010 for callers within the United States, and 617-801-6888 for international callers. Please use passcode 58872090 for the replay. This call is being webcast by CCBN, and can be accessed at PHC, Inc.’s web site at http://www.phc-inc.com/. The webcast is also being distributed over CCBN’s Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN’s individual investor center at http://www.fulldisclosure.com/, or by visiting any of the investor sites in CCBN’s Individual Investor Network. Institutional investors can access the call via CCBN’s password-protected event management site, StreetEvents, at http://www.streetevents.com/.

About Pioneer Behavioral Health

Pioneer Behavioral Health operates companies that provide inpatient and outpatient behavioral health care services, clinical research and Internet- and telephonic-based referral services. The companies contract with national insurance companies, government payors, and major transportation and gaming companies, among others, to provide such services. For more information, please visit http://www.phc-inc.com/ or http://www.haydenir.com/.

Statement under the Private Securities Litigation Reform Act of 1995:

Statement under the Private Securities Litigation Reform Act of 1995: This press release may include “forward-looking statements” that are subject to risks and uncertainties. Forward-looking statements include information about possible or assumed future results of the operations or the performance of the company and its future plans and objectives. Various future events or factors may cause the actual results to vary materially from those expressed in any forward-looking statements made in this press release. For a discussion of these factors and risks, see the company’s annual report on Form 10-K for the most recently ended fiscal year.

   Company Contact:                    Investor Relations Contact:   PHC, Inc.                           Hayden Communications, Inc.   Bruce A. Shear                      Matt Hayden or Peter Seltzberg   978-536-2777                        843-272-4653                               – tables follow –                             PHC, INC. AND SUBSIDIARIES                     CONDENSED CONSOLIDATED BALANCE SHEETS                                                 December 31,    June 30,                 ASSETS                             2006          2006   Current assets:                              (unaudited)     Cash and cash equivalents                   $4,150,210     $1,820,105     Accounts receivable, net of allowance      for doubtful accounts of $3,389,836      at December 31, 2006 and $3,100,586      at June 30, 2006                            6,736,235      6,955,475     Pharmaceutical receivables                   1,466,484      1,470,019     Prepaid expenses                               863,292        490,655     Other receivables and advances                 853,165        751,791     Deferred income tax asset                    2,918,779      3,110,000       Total current assets                      16,988,165     14,598,045     Accounts receivable, non-current                35,000         40,000     Other receivable                                47,680         53,457     Property and equipment, net                  2,018,990      1,799,888     Deferred financing costs, net of      amortization of $124,899 at      December 31, 2006 and $106,422      June 30, 2006                                  98,546        117,023     Customer relationships, net of      amortization of $320,000 at      December 31, 2006 and $260,000      at June 30, 2006                            2,080,000      2,140,000     Goodwill                                     3,164,643      2,664,643     Other assets                                   828,190        571,931       Total assets                             $25,261,214    $21,984,987   LIABILITIES AND STOCKHOLDERS’ EQUITY    Current liabilities:     Accounts payable and short-term      notes payable                              $1,903,578     $1,518,615     Current maturities of long-term debt         1,120,998        909,057     Revolving credit note                        1,105,949      1,603,368     Deferred revenue                               388,967        385,742     Current portion of obligations under      capital leases                                203,401         57,881     Accrued payroll, payroll taxes      and benefits                                1,510,571      1,619,672     Accrued expenses and other liabilities       1,248,154      1,026,419       Total current liabilities                  7,481,618      7,120,754     Long-term debt                               1,006,783      1,021,546     Obligations under capital leases                74,619         61,912     Deferred tax liability                         325,000        325,000       Total liabilities                          8,888,020      8,529,212    Stockholders’ equity:     Preferred Stock, 1,000,000 shares      authorized, none issued or outstanding             —             —     Class A common stock, $.01 par value,      30,000,000 shares authorized,      19,175,592 and 17,874,966 shares issued      at December 31, 2006 and June 30, 2006,      respectively                                  191,756        178,749     Class B common stock, $.01 par value,      2,000,000 shares authorized, 775,760      issued and outstanding at      December 31, 2006 and June 30, 2006,      respectively, each convertible into one      share of Class A common Stock                   7,758          7,758     Additional paid-in capital                  26,078,238     23,718,197     Treasury stock, 199,098 shares of      Class A common stock at      December 31, 2006 and June 30, 2006,      at cost                                      (191,700)      (191,700)     Accumulated deficit                         (9,712,858)   (10,257,229)     Total stockholders’ equity                  16,373,194     13,455,775     Total liabilities and stockholders’      equity                                    $25,261,214    $21,984,987                               PHC, INC. AND SUBSIDIARIES                CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS                                  (Unaudited)                          Three Months Ended          Six Months Ended                            December 31,               December 31,                          2006         2005         2006         2005   Revenues:     Patient      care, net        $7,946,670   $6,465,356  $15,823,102  $13,178,336     Pharmaceutical      studies             873,920    1,084,084    1,925,303    2,390,093     Contract support      services          1,131,770    1,153,073    2,266,161    2,078,910       Total revenues   9,952,360    8,702,513   20,014,566   17,647,339   Operating expenses:     Patient care      expenses          4,243,531    3,292,393    8,199,183    6,554,304     Patient care      expenses,      pharmaceutical      421,549      510,834      908,486    1,073,988     Cost of contract      support services    687,174      587,067    1,525,729    1,184,862     Provision for      doubtful accounts   347,458      475,768      799,983    1,132,655     Administrative      expenses          3,118,099    2,749,100    6,213,554    5,378,776     Administrative      expenses,      pharmaceutical      529,555      538,291    1,208,663    1,172,290       Total operating        expenses        9,347,366    8,153,453   18,855,598   16,496,875    Income from    operations            604,994      549,060    1,158,968    1,150,464     Other income      (expense):      Interest income      33,808       15,397       66,657       38,261      Other income       (expense)           (3,135)      21,263       (4,078)      32,048      Interest expense   (212,441)    (174,338)    (332,271)    (329,556)         Total other         expenses, net   (181,768)    (137,678)    (269,692)    (259,247)    Income before    provision for taxes   423,226      411,382      889,276      891,217   Provision for    income taxes          162,138       64,600      344,905      160,228    Net income            $261,088     $346,782     $544,371     $730,989    Basic net income    per common share        $0.01        $0.02        $0.03        $0.04    Basic weighted    average number    of shares    outstanding        18,758,151   18,159,188   18,636,146   18,125,265    Fully diluted    net income per    common share            $0.01        $0.02        $0.03        $0.04    Fully diluted    weighted average    number of shares    outstanding        19,409,232   19,301,486   19,280,727   19,302,592  

PHC, Inc.

CONTACT: Bruce A. Shear of PHC, Inc., +1-978-536-2777; or Matt Hayden orPeter Seltzberg, both of Hayden Communications, Inc., +1-843-272-4653, for

Web site: http://www.phc-inc.com/